Discontinued — last reported Q2 '20
West Pharmaceutical Services Weighted-Average Discount Rate decreased by 1.2% to 4.1% in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.9%, from 4.5% to 4.1%.
An increase reflects higher market interest rates or increased company-specific borrowing costs, which may impact future cash flow projections.
This is the average interest rate used to calculate the present value of future lease payments for operating and finance...
Generally aligns with prevailing market interest rates and the company's credit profile.
weighted_average_discount_rate| Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | 4.9% | 4.9% | 4.8% | 4.5% | 4.3% | 4.2% | 4.2% | 4.1% |
| QoQ Change | — | -0.4% | -2.4% | -7.3% | -3.8% | -2.8% | -0.2% | -1.2% |
| YoY Change | — | — | — | — | -13.4% | -15.4% | -13.5% | -7.9% |